Rocket


News + Filings
Transactions
Holdings





All
13F
13D/G
Other



DUGGAN ROBERT W Create: Alert

All | News | Filings
Date FiledTypeDescription
07/27/2023 4 DUGGAN ROBERT W (10% Owner) has filed a Form 4 on Pulse Biosciences, Inc.
Txns: Exercised 1,667 options to buy @ $5.95, valued at $9.9k
07/07/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/16/2023 4 DUGGAN ROBERT W (10% Owner) has filed a Form 4 on Pulse Biosciences, Inc.
Txns: Exercised (in-or-at-the-money) 5,683,163 warrants @ $2.05, valued at $11.7M
Exercised (in-or-at-the-money) 81,025 warrants @ $2.05, valued at $166.1k
06/06/2023 4 DUGGAN ROBERT W (10% Owner) has filed a Form 4 on Pulse Biosciences, Inc.
Txns: Granted 20,000 options to buy @ $5.95, valued at $119k
Granted 39,731 options to buy @ $5.95, valued at $236.4k
05/10/2023 SC 13D/A DUGGAN ROBERT W reports a 68.7% stake in Pulse Biosciences, Inc.
05/10/2023 4 DUGGAN ROBERT W (10% Owner) has filed a Form 4 on Pulse Biosciences, Inc.
Txns: Bought 10,022,937 shares @ $6.51, valued at $65.2M
03/08/2023 4 DUGGAN ROBERT W (CEO) has filed a Form 4 on Summit Therapeutics Inc.
Txns: Bought 376,489,880 shares @ $1.05, valued at $395.3M
12/09/2022 SC 13D/A DUGGAN ROBERT W reports a 81.8% stake in Summit Therapeutics Inc.
12/08/2022 4 DUGGAN ROBERT W (CEO) has filed a Form 4 on Summit Therapeutics Inc.
Txns: Acquired 9,346,434 shares @ $0
08/18/2022 SC 13D/A DUGGAN ROBERT W reports a 81.2% stake in Summit Therapeutics Inc.
08/18/2022 4 DUGGAN ROBERT W (CEO) has filed a Form 4 on Summit Therapeutics Inc.
Txns: Bought 94,849,203 shares @ $0.97, valued at $92M
06/10/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/10/2022 SC 13D/A Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
05/25/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
05/23/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/02/2021 SC 13D/A DUGGAN ROBERT W reports a 51.2% stake in Pulse Biosciences, Inc.
07/02/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
05/21/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
05/14/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
05/14/2021 SC 13D/A DUGGAN ROBERT W reports a 70.8% stake in Summit Therapeutics Inc.
05/11/2021 SC 13D/A Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
04/22/2021 SC 13D/A Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
03/26/2021 SC 13D/A Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
12/30/2020 4 DUGGAN ROBERT W (10% Owner) has filed a Form 4 on Pulse Biosciences, Inc.
Txns: Exercised (in-or-at-the-money) 376,065 warrants @ $7.01, valued at $2.6M
Exercised (in-or-at-the-money) 8,214 warrants @ $7.01, valued at $57.6k
11/10/2020 4 DUGGAN ROBERT W (CEO) has filed a Form 4 on Summit Therapeutics Inc.
Txns: Bought 14,071,856 shares @ $3.34, valued at $47M
11/10/2020 SC 13D/A DUGGAN ROBERT W reports a 69.9% stake in Summit Therapeutics Inc.
10/06/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
10/06/2020 SC 13D/A Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
09/28/2020 SC 13D Form SC 13D - General statement of acquisition of beneficial ownership:
09/18/2020 3 DUGGAN ROBERT W (See Remarks) has filed a Form 3 on Summit Therapeutics Inc.
06/17/2020 SC 13D/A DUGGAN ROBERT W reports a 47.2% stake in Pulse Biosciences, Inc.
06/17/2020 4 DUGGAN ROBERT W (10% Owner) has filed a Form 4 on Pulse Biosciences, Inc.
Txns: Exercised (in-or-at-the-money) 2,507,112 shares @ $7.01, valued at $17.6M
Exercised (in-or-at-the-money) 54,761 shares @ $7.01, valued at $383.9k
Bought 376,065 warrants @ $7.01, valued at $2.6M
Bought 8,214 warrants @ $7.01, valued at $57.6k
05/19/2020 4 DUGGAN ROBERT W (10% Owner) has filed a Form 4 on Pulse Biosciences, Inc.
Txns: Granted 20,000 options to buy @ $10.66, valued at $213.2k
Granted 20,347 options to buy @ $10.66, valued at $216.9k
01/16/2020 SC 13D/A DUGGAN ROBERT W reports a 64.9% stake in Summit Therapeutics PLC
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy